![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Exposure-Efficacy Analysis for Daclatasvir and Asunaprevir in DUAL Combination in Non-Japanese and Japanese Subjects with Genotype 1b Hepatitis C Virus Infection
|
|
|
Reported by Jules Levin
APASL 2015
24th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2015). Istanbul, Turkey, March 12-15, 2015
Zhu L,1 Chan P,1 Eley T,1 Bifano M,1 Osawa M,2 Ueno T,2 Hughes E,1 AbuTarif M,1 Cirincione B,1 LaCreta F,1 Garimella T1
1Bristol-Myers Squibb Research and Development, Princeton, NJ, USA; 2Bristol-Myers K.K., Tokyo, Japan
![APASL1.gif](../images/031815/031815-5/APASL1.gif)
![APASL2.gif](../images/031815/031815-5/APASL2.gif)
![APASL3.gif](../images/031815/031815-5/APASL3.gif)
![APASL4.gif](../images/031815/031815-5/APASL4.gif)
![APASL5.gif](../images/031815/031815-5/APASL5.gif)
![APASL6.gif](../images/031815/031815-5/APASL6.gif)
![APASL7.gif](../images/031815/031815-5/APASL7.gif)
![APASL8.gif](../images/031815/031815-5/APASL8.gif)
![APASL9.gif](../images/031815/031815-5/APASL9.gif)
![APASL10.gif](../images/031815/031815-5/APASL10.gif)
![APASL11.gif](../images/031815/031815-5/APASL11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|